Visualization analysis of stem cell therapy for myocardial infarction based on Web of Science in recent ten years
- VernacularTitle:基于Web of Science近十年干细胞治疗心肌梗死的可视化分析
- Author:
Yukang SUN
1
;
Lijuan SONG
;
Chunli WEN
;
Zhibin DING
;
Hao TIAN
;
Dong MA
;
Cungen MA
;
Xiaoyan ZHAI
Author Information
- Keywords: stem cell; myocardial infarction; bibliometrics; knowledge map; visualization analysis; CiteSpace; VOSviewer
- From: Chinese Journal of Tissue Engineering Research 2024;28(7):1143-1148
- CountryChina
- Language:Chinese
- Abstract: BACKGROUND:Although traditional therapies,including drugs and surgery,cannot repair the damaged myocardial tissue,the mortality rate of myocardial infarction remains high.Stem cells provide the possibility to solve this problem due to their self-renewal and multi-directional differentiation potential. OBJECTIVE:To analyze the research progress of stem cell therapy for myocardial infarction in recent ten years by bibliometric analysis. METHODS:The related articles on stem cells and myocardial infarction published in SCI-E and SSCI from January 1,2012 to December 1,2022 in the Web of Science database were searched.EXCEL,CiteSpace and VOSviewer software were used to make statistical and visualization analyses of the data such as the number of publications,authors,institutions,journals,countries and keywords. RESULTS AND CONCLUSION:A total of 3 210 core articles were published,and the total number increased year by year.hausenloy,derek j.is the author with the largest number of publications,China is the country with the largest number of publications,and the Fourth Military Medical University is the institution with the largest number of publications.The research hotspots in this field are changing from cell experiments and animal experiments to clinical trials.In the past ten years,research in this field has been highly popular and still has great development prospects.It is necessary to promote international and inter-agency exchange and learning,and further explore the role of stem cells in the treatment of myocardial infarction.
